Matinas BioPharma Holdings Inc (FRA:6LJ0)
€ 2.69 0 (0%) Market Cap: 15.88 Mil Enterprise Value: 5.92 Mil PE Ratio: 0 PB Ratio: 0.92 GF Score: 52/100

Matinas BioPharma Holdings Inc Annual Shareholders Meeting Transcript

Nov 01, 2023 / 01:00PM GMT
Release Date Price: €8.75 (-1.13%)
Operator

Thank you for holding, and welcome everyone to the Matinas Biopharma Annual Meeting of Stockholders. (Operator Instructions) Thank you. I will now turn the call over to Jerry Jabbour.

Jerry Jabbour
Matinas Biopharma - CEO

Good morning. I'm Jerry Jabbour, Chief Executive Officer of Matinas Biopharma Holdings, Inc. On behalf of the officers and the Board of Directors of Martinez, I would like to welcome you to our Annual Meeting of Stockholders. We are pleased to have each of you participating virtually.

We will begin with the formal business of the Annual Meeting contained in the proxy materials previously mailed to all stockholders. We have scheduled and announced our third quarter 2023 update call for November 8, 2023, and we'll provide a business update at that time, so we will not include a formal presentation during this morning's meeting. You will, however, have the opportunity to submit questions regarding the company following the conclusion of the formal meeting this morning.

Also if you have questions regarding the matters to be

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot